22nd Annual Meeting of the Society for the Study of Ingestive Behavior: Seattle, WA, USA, 2014
Doses in the 100 to 200mcg per day range, if accompanied by selenium, pose virtually no risk to your health and may actually be very helpful
However, coverage varies by plan and typically requires prior authorization or step therapy to demonstrate medical necessity
THIS PRODUCT IS NOT INTENDED TO DIAGNOSE, TREAT, CURE OR PREVENT ANY DISEASE.
While diarrhea can be a frustrating side effect, it may help to know that its quite common among tirzepatide patients
Unlike the well-studied CagriSema combination (cagrilintide + semaglutide) with proven 15-25% weight loss results from Phase 3 trials, adding cagrilintide to tirzepatide remains completely unstudied